The administration of synthetic CNP or stabilized peptide mimetics has shown protective effects against hypertrophy and fibrosis in preclinical models of pathological cardiac remodeling, such as those involving experimentally induced myocardial infarction [41,42]. Here, CNP is linked to myocardial infarction.